PFE
30
-3
CCL
68
-4
PNC
57
-2
NVDA
52
-3
WMB
60
4
KHC
59
14
SJM
38
-3
NAVI
55
-2
NI
65
2
GPC
37
-14
DNB
50
-4
CMA
62
-2
HSIC
50
-3
WU
12
-4
DIS
60
2
NEM
48
2
PEG
76
5
LLY
48
-2
FAST
46
-3
APA
25
-3
PFE
30
-3
CCL
68
-4
PNC
57
-2
NVDA
52
-3
WMB
60
4
KHC
59
14
SJM
38
-3
NAVI
55
-2
NI
65
2
GPC
37
-14
DNB
50
-4
CMA
62
-2
HSIC
50
-3
WU
12
-4
DIS
60
2
NEM
48
2
PEG
76
5
LLY
48
-2
FAST
46
-3
APA
25
-3
Financhill
Back

Invesco S&P 500® Equal Weight ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
57

RSP
Invesco S&P 500® Equal Weight ETF

Last Price:
177.42
Seasonality Move:
1.83%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
57
Invesco S&P 500® Equal Weight ETF (RSP) is a Buy

Is Invesco S&P 500® Equal Weight ETF a Buy, Sell or Hold?

  • The current Invesco S&P 500® Equal Weight ETF [RSP] share price is $177.44. The Score for RSP is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • RSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RSP Stock Price Chart

What is Invesco S&P 500® Equal Weight ETF's stock price today?

  • The Invesco S&P 500® Equal Weight ETF share price today is $177.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.77 Buy
Relative Strength Index (14 RSI): 65.37 Buy
Chaikin Money Flow: 3835637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (171.79 - 175.83) Buy
Bollinger Bands (100): (163.82 - 172.08) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

RSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 175.65 Buy
20-day SMA: 174.32 Buy
50-day SMA: 171.02 Buy
200-day SMA: 164.05 Buy
8-day EMA: 175.99 Buy
20-day EMA: 174.18 Buy
50-day EMA: 171.42 Buy
200-day EMA: 163.85 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Invesco S&P 500® Equal Weight ETF Earnings Growth & RSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Invesco S&P 500® Equal Weight ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):